Table 3.
Individual worm genotypes at the 198 and 200 SNP positions in isotype 1 beta-tubulin for Wallangra worms not exposed to thiabendazole and the survivors of exposure to the drug at 2.6 μg/ml in larval development assays.
| Genotypea | Wallangrab |
Wallangra 2.6 μg/mlc |
||
|---|---|---|---|---|
| Number of larvae | % of total | Number of larvae | % of total | |
| Hs-198, Hs-200 | 0 | 0 | 0 | 0 |
| Het-198, Hs-200 | 4 | 7.2 | 0 | 0 |
| Hs-198, Het-200 | 1 | 1.8 | 0 | 0 |
| Het-198, Het-200 | 25 | 45.5 | 0 | 0 |
| Hs-198, HR-200 | 12 | 21.8 | 0 | 0 |
| HR-198, Hs-200 | 13 | 23.7 | 62 | 100 |
| HR-198, Het-200 | 0 | 0 | 0 | 0 |
| Het-198, HR-200 | 0 | 0 | 0 | 0 |
| HR-198, HR-200 | 0 | 0 | 0 | 0 |
a
Hs = homozygous susceptible; Het = heterozygote; HR = homozygous resistant.
b
Total of 55 larvae genotyped from the group not exposed to drug.
c
Total of 62 larvae genotyped from the group which survived 2.6 μg/ml thiabendazole.